|Bid||63.09 x 800|
|Ask||63.08 x 1100|
|Day's Range||62.11 - 63.42|
|52 Week Range||60.89 - 85.97|
|Beta (5Y Monthly)||0.58|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct. 22, 2020 - Oct. 26, 2020|
|Forward Dividend & Yield||2.72 (4.33%)|
|Ex-Dividend Date||Sep. 14, 2020|
|1y Target Est||79.08|
Diodes Incorporated (Nasdaq: DIOD) today announced the introduction of the PS508 and PS509 analog multiplexers that are capable of switching signal voltages of up to 36V in an industrial environment. The high voltage capability of the devices will support industrial IoT (IIoT) applications using multiple sensors, including factory automation and process control, battery monitoring systems, and test and measurement equipment.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the HIV Glasgow 2020 conference, taking place virtually from October 5-8. Gilead will present 13 studies from the company’s HIV research and development programs in addition to supporting several other independent studies at the conference, which, along with its community-focused programs, reflect Gilead’s ongoing focus and commitment to advancing scientific discovery and supporting the development and delivery of practical solutions that can help improve care for all people affected by HIV.
These big biotechs are both moving into new areas. Which is most likely to move the needle for investors?